[go: up one dir, main page]

ATE277921T1 - CANNABINOIDS SELECTIVELY ACTING ON THE CB2 RECEPTOR - Google Patents

CANNABINOIDS SELECTIVELY ACTING ON THE CB2 RECEPTOR

Info

Publication number
ATE277921T1
ATE277921T1 AT99921676T AT99921676T ATE277921T1 AT E277921 T1 ATE277921 T1 AT E277921T1 AT 99921676 T AT99921676 T AT 99921676T AT 99921676 T AT99921676 T AT 99921676T AT E277921 T1 ATE277921 T1 AT E277921T1
Authority
AT
Austria
Prior art keywords
receptor
cannabinoids
cannabinoid
novel
ring
Prior art date
Application number
AT99921676T
Other languages
German (de)
Inventor
Alexandros Makriyannis
Atmaram Khanolkar
Dai Lu
Original Assignee
Univ Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Connecticut filed Critical Univ Connecticut
Application granted granted Critical
Publication of ATE277921T1 publication Critical patent/ATE277921T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed are novel cannabinoids which are selective for the CB2 receptor. The novel cannabinoids comprise a substituted or unsubstituted tricyclic cannabinoid core and a substituted or unsubstituted C5-C8 carbocyclic ring, five to eight-membered heterocyclic ring or a seven to ten membered bicyclic ring system fused to the monhydroxylated phenyl ring of the cannabinoid core. Also disclosed are methods of suppressing the immune system in a subject by administering to the subject a (e.g. immunosuppressive amount) effective amount of a novel cannabinoid described above.
AT99921676T 1998-05-04 1999-05-04 CANNABINOIDS SELECTIVELY ACTING ON THE CB2 RECEPTOR ATE277921T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8412998P 1998-05-04 1998-05-04
PCT/US1999/009806 WO1999057107A2 (en) 1998-05-04 1999-05-04 Cannabinoids selective for the cb2 receptor

Publications (1)

Publication Number Publication Date
ATE277921T1 true ATE277921T1 (en) 2004-10-15

Family

ID=22183058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921676T ATE277921T1 (en) 1998-05-04 1999-05-04 CANNABINOIDS SELECTIVELY ACTING ON THE CB2 RECEPTOR

Country Status (7)

Country Link
US (1) US6166066A (en)
EP (1) EP1076653B1 (en)
AT (1) ATE277921T1 (en)
CA (1) CA2340444A1 (en)
DE (1) DE69920683T2 (en)
ES (1) ES2224658T3 (en)
WO (1) WO1999057107A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2340444A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Cannabinoids selective for the cb2 receptor
CA2340445A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7235584B2 (en) * 2000-06-22 2007-06-26 Pharmos Corporation Non-psychotropic cannabinoids
WO2001098289A1 (en) * 2000-06-22 2001-12-27 Pharmos Corporation Novel non-psychotropic cannabinoids
EP1361876A4 (en) * 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
EP1363632B1 (en) 2001-01-29 2010-08-25 The University of Connecticut Receptor selective cannabimimetic aminoalkylindoles
WO2003005960A2 (en) * 2001-07-13 2003-01-23 University Of Connecticut Novel bicyclic and tricyclic cannabinoids
EP1448557A4 (en) * 2001-10-26 2005-02-02 Univ Connecticut HETEROINDANES: NEW CLASS OF EFFECTIVE CANNABIMIMETIC LIGANDS
WO2003049727A1 (en) * 2001-12-07 2003-06-19 Virginia Commonwealth University Treatment of neoplasia
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
AU2003233172A1 (en) 2002-06-06 2004-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
CN1678303A (en) 2002-08-23 2005-10-05 康涅狄格大学 Therapeutic Keto Cannabinoids
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
WO2005123053A2 (en) * 2004-06-22 2005-12-29 Pharmos Limited Use of cb2 receptors agonists for the treatment of huntington’s disease
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US9575319B2 (en) 2014-03-10 2017-02-21 Ion Virtual Technology Corporation Method and system for reducing motion blur when experiencing virtual or augmented reality environments
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
BR112019026916A2 (en) 2017-06-20 2020-06-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. cannabidiolic acid ester compositions and uses thereof
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US3886184A (en) * 1973-08-03 1975-05-27 Lilly Co Eli Aminodibenzo(b,d)pyrans
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5440052A (en) * 1993-08-06 1995-08-08 University Of Connecticut Compositions useful as a cannabinoid receptor probe
FR2735774B1 (en) * 1995-06-21 1997-09-12 Sanofi Sa USE OF HUMAN CB2 RECEPTOR AGONIST COMPOUNDS FOR THE PREPARATION OF IMMUNOMODULATORY DRUGS, NOVEL CB2 RECEPTOR AGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents
CA2340444A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Cannabinoids selective for the cb2 receptor
CA2340445A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids

Also Published As

Publication number Publication date
EP1076653B1 (en) 2004-09-29
WO1999057107A3 (en) 2000-02-03
US6166066A (en) 2000-12-26
DE69920683D1 (en) 2004-11-04
WO1999057107A2 (en) 1999-11-11
CA2340444A1 (en) 1999-11-11
EP1076653A2 (en) 2001-02-21
ES2224658T3 (en) 2005-03-01
DE69920683T2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
ATE277921T1 (en) CANNABINOIDS SELECTIVELY ACTING ON THE CB2 RECEPTOR
DE69605430D1 (en) CHINOLIN-2-ON DERIVATIVES AS SEROTONIN ANTAGONISTS
ID26697A (en) NEUROTROFIN PURIFICATION
ES2107518T3 (en) STABILIZED POLYMERS WITH HETEROATOMES IN THE MAIN CHAIN.
EA199700156A1 (en) INDOL DERIVATIVES AS ANTAGONISTS OF 5-HT RECEPTOR
TR200000782T2 (en) Resorcinol derivatives.
ATE254456T1 (en) CANNABINOID RECEPTOR ANTAGONISTS
TR199900501T2 (en) Benzamine derivatives and their use as medicine.
NO891309D0 (en) PROCEDURE FOR SEPARATION OF HYDRO-TREATED WASTE FLOWS.
TR200003470T2 (en) Ecteinascidin 743 Metabolites
DE3481168D1 (en) SEBOSUPPRESSIVE COSMETIC AGENT, CONTAINING BENZYL ALCOHOL DERIVATIVES.
FI974434L (en) Tricyclic 5,6-dihydro-9H-pyrazolo(3,4-c)-1,2,4,-triazolo(4,3-alphapyridines
ES2171911T3 (en) CONFORMATIONALLY RESTRICTED POLYAMINS AND ITS USE AS ANTINEOPLASIC AGENTS.
DK0983275T3 (en) New triptolide derivatives useful for the treatment of autoimmune diseases
FI964045L (en) CCK or gastrin-regulating 5-heterocyclic-1,5-benzodiazepines
DE59607649D1 (en) Di-1,3-dioxane derivatives as liquid crystals
TR199801612T2 (en) Formulas and methods containing benzothiophene, benzothiophene.
ES2140672T3 (en) REPLACED BICYCLE COMPOUNDS, MERGED AND BRIDGES USED AS THERAPEUTIC AGENTS.
DE69703788D1 (en) High molecular weight dibenzoylresorcinol as UV absorber
FR2732048B1 (en) REMOVABLE BRIDGE ASSEMBLED BY SPARE PARTS
EA199800029A1 (en) METHOD OF OBTAINING BENZO [b] TIOPHENES
DE69724000D1 (en) INDANE OR DIHYDROINDOL DERIVATIVES
DE69706441D1 (en) TETRACYCLIC AROMATIC RETINOID COMPOUNDS, THEIR PRODUCTION AND USE
FI861828L (en) VID RYGGEN AV EN PAERM FASTSAETTBAR FAESTANORDNING FOER BOECKER, TIDSKRIFTER OCH DYLIKA.
Azuma The Analysis of the Case of Planning for Moved Villedge which suffered from flood changjiang

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties